JOURNEY MEDICAL CORP (DERM) Stock Price & Overview
NASDAQ:DERM • US48115J1097
Current stock price
The current stock price of DERM is 6.83 USD. Today DERM is down by -1.16%. In the past month the price decreased by -21.72%. In the past year, price increased by 11.78%.
DERM Key Statistics
- Market Cap
- 186.186M
- P/E
- N/A
- Fwd P/E
- 26.52
- EPS (TTM)
- -0.58
- Dividend Yield
- N/A
DERM Stock Performance
DERM Stock Chart
DERM Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to DERM. When comparing the yearly performance of all stocks, DERM is a bad performer in the overall market: 61.77% of all stocks are doing better.
DERM Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DERM. DERM may be in some trouble as it scores bad on both profitability and health.
DERM Earnings
On March 25, 2026 DERM reported an EPS of -0.04 and a revenue of 16.08M. The company beat EPS expectations (31.8% surprise) and missed revenue expectations (-16.42% surprise).
DERM Forecast & Estimates
10 analysts have analysed DERM and the average price target is 13.77 USD. This implies a price increase of 101.61% is expected in the next year compared to the current price of 6.83.
For the next year, analysts expect an EPS growth of 52% and a revenue growth 13.98% for DERM
DERM Groups
Sector & Classification
DERM Financial Highlights
Over the last trailing twelve months DERM reported a non-GAAP Earnings per Share(EPS) of -0.58. The EPS increased by 41.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.17% | ||
| ROE | -33.45% | ||
| Debt/Equity | 0.75 |
DERM Ownership
DERM Latest News, Press Relases and Analysis
DERM Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.21 | 851.873B | ||
| JNJ | JOHNSON & JOHNSON | 20.6 | 566.674B | ||
| MRK | MERCK & CO. INC. | 23.07 | 287.712B | ||
| PFE | PFIZER INC | 9.14 | 153.358B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.31 | 116.873B | ||
| ZTS | ZOETIS INC | 16.49 | 48.938B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.1 | 26.288B | ||
| VTRS | VIATRIS INC | 5.38 | 15.383B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.24 | 12.38B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.12B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.658B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.31B | ||
| LGND | LIGAND PHARMACEUTICALS | 24.09 | 4.021B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About DERM
Company Profile
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company is headquartered in Scottsdale, Arizona and currently employs 41 full-time employees. The company went IPO on 2021-11-12. The firm is focused on selling and marketing of the United States Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved FDA for sale in the United States, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne. Luxamend is a water-based emulsion formulated to provide moist healing environment.
Company Info
IPO: 2021-11-12
JOURNEY MEDICAL CORP
9237 E Via De Ventura Blvd., Suite 105, Suite 105
Scottsdale ARIZONA 94025 US
CEO: Thomas G. Wiggans
Employees: 41
Phone: 14804346670
JOURNEY MEDICAL CORP / DERM FAQ
What does JOURNEY MEDICAL CORP do?
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company is headquartered in Scottsdale, Arizona and currently employs 41 full-time employees. The company went IPO on 2021-11-12. The firm is focused on selling and marketing of the United States Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved FDA for sale in the United States, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne. Luxamend is a water-based emulsion formulated to provide moist healing environment.
Can you provide the latest stock price for JOURNEY MEDICAL CORP?
The current stock price of DERM is 6.83 USD. The price decreased by -1.16% in the last trading session.
Does DERM stock pay dividends?
DERM does not pay a dividend.
How is the ChartMill rating for JOURNEY MEDICAL CORP?
DERM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the market cap for JOURNEY MEDICAL CORP?
JOURNEY MEDICAL CORP (DERM) has a market capitalization of 186.19M USD. This makes DERM a Micro Cap stock.
What is the ownership structure of JOURNEY MEDICAL CORP (DERM)?
You can find the ownership structure of JOURNEY MEDICAL CORP (DERM) on the Ownership tab.
Can you provide the short interest for DERM stock?
The outstanding short interest for JOURNEY MEDICAL CORP (DERM) is 12.61% of its float.